Tag Archive for: STIMULAN

Biocomposites announces two new Phase II clinical trials of STIMULAN VG – a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin – in the U.S.

/in

BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitis BLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcers Keele, UK, 7 February 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management […]

Read more

Biocomposites expands its international presence by opening new sales and distribution office in Italy

/in

Biocomposites SRL will support sales of STIMULAN, NanoBone, genex and SYNICEM Spacers throughout Italy New team has been hired and first sales have already taken place Keele, UK, 16 January 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for use in infection management in bone and soft tissue, is pleased […]

Read more

Biocomposites exceeds revenue expectations and takes a big step forward in its research and development collaboration with Swiss innovator CSEM

/in

New record for sales growth and number of patients supported Product portfolio enhanced through acquisition of NanoBone® and expansion of STIMULAN® approval as an antibiotic carrier to treat bacterial infection Research and Development boosts with STIMULAN VG moving to phase II clinical trial and investment in Renovite Keele, UK, 13 December 2023 – Biocomposites, an international […]

Read more

Biocomposites announces new territories approved to promote STIMULAN­® as an antibiotic carrier in bone and soft tissue

/in

Argentina and Taiwan added to list of approved territories STIMULAN gives surgeons the freedom to choose the antibiotics that support their infection treatment strategy Keele, UK, 11 October 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased […]

Read more

STIMULAN® now available in South Africa to treat bacterial infection

/in

Novus Healthcare will exclusively distribute STIMULAN® and genex in South Africa Keele, UK, 10 May 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial […]

Read more